October 6, 2019The Russian Archives of Internal MedicineOpen Access

Current View on Anticoagulant and Thrombolytic Treatment of Acute Pulmonary Embolism

View Full Paper

Ask AI

Bookmark

Design

Review

Authors

ГТГ. Г. ТарадинDonetsk National Medical University ГИГ. А. ИгнатенкоDonetsk National Medical University НВН. Т. ВатутинDonetsk National Medical University

Discussion

Member takes

Implication

Offers clinicians a concise update on acute PE pathways; leaves open the need for prospective trials to refine protocols.

Structured PICO

Population

Patients with venous thromboembolism and acute pulmonary embolism

Intervention

Anticoagulant treatment (including apixaban, rivaroxaban, dabigatran, edoxaban, betrixaban) and systemic thrombolysis (intravenous streptokinase, urokinase, tissue plasminogen activators)

This review summarizes contemporary approaches to the multidisciplinary management, anticoagulant therapy, and systemic thrombolysis for acute pulmonary embolism.

Cite This Study

Тарадин et al. (2019) studied this question.

synapsesocial.com/papers/6a8bdf493fd21775a533c1e7 https://doi.org/10.20514/2226-6704-2019-9-5-348-366

View Full Paper

Ask AI

Bookmark